Background and study aim: Cirrhotic patients are more vulnerable to bacterial infection. Pneumonia is the fourth most common infection, particularly in advanced disease. Antimicrobial resistance (AMR) has great concern among cirrhotic. The aim of this study was to characterize the AMR, distribution of bacteria isolated from chronic hepatic patients with pulmonary infections, and evaluation the antimicrobial susceptibility of bacteria isolated from sputum. Patients and Methods: This cross-sectional observational study was carried on 98 cirrhotic patients with healthcare-associated pneumonia. Antimicrobial susceptibility testing was conducted using the Kirby–Bauer disc diffusion process according to Clinical and Laboratory Standards Institute (CLSI) guidelines for various therapeutically applicable antibiotics. Data manipulation was done using Microsoft Excel® spreadsheet. Results: The most common organisms isolated from sputum samples in the present study were E coli (19.39%), Klebsiella spp (15.31%), Staph aureus (14.29%) and Pseudomonas (9.18%) while no growth of organisms observed in 28.58%. The antimicrobial-susceptibility for Enterobacteriaceae species isolated from sputum showed higher sensitivity to Imipenem (88.2%), Piperacillin – tazobactam (73.5%), and Ampicillin (70.59%) while Ceftriaxone , Ceftazidime and Cefotaxime showed higher resistance respectively (64.71%, 58.82% and 55.89%). The antimicrobial-susceptibility results for S.aureus species isolated from sputum showed higher sensitivity to Vancomycin (100%) followed by Oxacillin ( 64.29%) while Penicillin G showed complete resistance 100%, followed by Tetracycline 92.86% ,and Co- trimoxazole 85.71%. Conclusion: Gram-negative bacteria were the cause of bacterial infections in significant proportion of patients with increased sensitivity to B-lactam antibiotics and ampicillin. However third and fourth generation cephalosporin had the higher resistance values.